FOSTERING NEXT GENERATION OF LIVING DRUGS
Center for IPS cell therapy
Our first Mission is to build the French National Bank of GMP IPSC
The reason why of a national bank is to :
- minimise cost, logistics, redundancy & to increase the chance to finding rare HLA-matched donors
- Guarantee high standard of quality control & ethical applications
A French center for IPS cell based therapies
CITHERA is developing the national bank of clinical grade pluripotent stem cells and new cellular biomedicines to fight cancer. This Center of the University of Paris Saclay, Inserm and the University of Evry at Genopole, is directed by Professor Annelise Bennaceur Griscelli and it is attached to the INSERM UA09 Unit ‘Malignant and therapeutic stem cell models’ under the direction of Professor Ali Turhan in Villejuif, near Paris . CITHERA was awarded as Industrial integrator by the « Grand Défi » from the Government recovery plan innovation council.
CITHERA is the platform that coordinates the INGESTEM infrastructure of the medical and industrial exploitation sector of IPSC stem cells and its mission is to build the clinical grade iPSC bank with the know-how acquired since the derivation of the first ESC lines in 2006 then IPSC in 2008.
CiTHERA, founding member of the MAGENTA industrial integrator
Cithera est maintenant labelisé par le gouvernement Intégrateur Industriel
Labellisation des intégrateurs industriels par le Grand défi "Biomédicaments" Le Grand Défi "Biomédicaments : améliorer les rendements et maîtriser les coûts de production" a labellisé diverses plateformes technologiques qui deviennent les intégrateurs industriels du...